Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
Patients with new-onset diabetes and unexplained weight loss — a known red-flag combo for pancreatic cancer — are rarely being referred for further investigation. A UK study found that among adults 60 and older meeting these criteria, only about 1 in 4 received a referral for suspected pancreatic cancer, and just 1 in 10 got abdominal imaging, suggesting a significant gap in adherence to NICE guidelines.
Pancreatic cancer is notoriously hard to catch early, and a new UK study suggests primary care may be missing a critical window. Researchers analyzed data from over 780 UK primary care practices and found that among adults 60 and older with new-onset diabetes and unexplained weight loss — a recognized warning sign combination — referral and imaging rates for suspected pancreatic cancer were strikingly low, pointing to a potential gap in guideline adherence.
The retrospective cohort study included over 180,000 patients diagnosed with diabetes between 2015 and 2021. Only 1.3% of all patients had unexplained weight loss recorded around the time of their diabetes diagnosis, and of those, just 21.6% had any referral code for suspected pancreatic cancer. Among the higher-risk 60+ age group, referral rates reached only 26.4%, with abdominal imaging ordered in just 10% of cases.
By the Numbers:
Why it matters: Pancreatic cancer has one of the lowest survival rates of any cancer, largely because it's often caught too late. New-onset diabetes combined with weight loss is a well-established early warning signal, and NICE guidelines already recommend referral in this scenario. Closing this gap in primary care could meaningfully improve early detection and patient outcomes.
